华纳药厂：2025年净利润同比增长46.95%

Core Insights - Warner Pharmaceuticals reported a revenue of 1.516 billion yuan for the fiscal year 2025, representing a year-on-year growth of 7.26% [1] - The net profit attributable to shareholders reached 241 million yuan, showing a significant increase of 46.95% compared to the previous year [1] - Basic earnings per share were reported at 1.84 yuan, reflecting a growth of 47.20% year-on-year [1]